637.86
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt IDXX?
Forum
Prognose
Aktiensplit
Finanzdaten der Idexx Laboratories Inc-Aktie (IDXX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
4.63%
998.43
|
954.29 | 975.54 | 1,003.58 | 964.10 |
Cost Of Revenue |
2.24%
375.05
|
383.63 | 379.50 | 384.42 | 371.02 |
Gross Profit |
9.24%
623.38
|
570.66 | 596.04 | 619.16 | 593.07 |
|
0.69%
306.85
|
308.97 | 292.15 | 355.36 | 294.11 |
Benefits Costs and Expenses |
1.37%
688.34
|
697.90 | 676.63 | 744.52 | 668.62 |
Costs And Expenses |
1.37%
688.34
|
697.90 | 676.63 | 744.52 | 668.62 |
Provision For Loan, Lease, And Other Losses |
61.72%
2.89
|
1.787 | 1.337 | 2.213 | 1.53 |
Operating Income/Loss |
20.96%
316.53
|
261.69 | 303.89 | 263.80 | 298.96 |
Income/Loss From Continuing Operations Before Tax |
20.94%
310.08
|
256.39 | 298.91 | 259.06 | 295.48 |
Income Tax Expense/Benefit |
67.52%
67.41
|
40.24 | 66.07 | 55.76 | 59.90 |
Income/Loss From Continuing Operations After Tax |
12.27%
242.68
|
216.15 | 232.84 | 203.30 | 235.58 |
|
12.27%
242.68
|
216.15 | 232.84 | 203.30 | 235.58 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
39,196%
81.32
|
-0.208 | 82.30 | 82.63 | 83.10 |
Diluted Average Shares |
35,411%
81.92
|
-0.232 | 83.06 | 83.39 | 83.96 |
Basic Earnings Per Share |
12.45%
2.98
|
2.65 | 2.83 | 2.46 | 2.84 |
Diluted Earnings Per Share |
12.98%
2.96
|
2.62 | 2.80 | 2.44 | 2.81 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):